Ectopic Pregnancy: Symptoms, Diagnosis and Treatment
Ectopic pregnancy: what it is, symptoms, diagnosis, and updated treatment 2026
Everything you need to know about ectopic pregnancy — from the classic triad of symptoms to the serial β-hCG protocol, key ultrasound findings, and current treatment options in 2026
If you have a positive pregnancy test and experience sudden, severe abdominal pain, dizziness or fainting, or vaginal bleeding with pain, you should go to the emergency room immediately. A ruptured ectopic pregnancy is a medical emergency that can be fatal if not treated urgently.
Ectopic pregnancy — also called ectopic pregnancy — occurs when the fertilized egg implants outside the uterine cavity. It is the leading cause of maternal death in the first trimester of pregnancy worldwide, and in Colombia it remains a diagnostic challenge because its initial symptoms are indistinguishable from a normal pregnancy. Diagnosing it on time, with the right tools, saves lives.
1. What is ectopic pregnancy?
Ectopic or ectopic pregnancy is when the fertilized egg does not implant in the endometrium of the uterine cavity, but stops and nests elsewhere. The most common site — in 96–98% of cases — is the fallopian tubes, which is why it is also called tubal pregnancy. The rest can implant in the ovary, the cervix, the scar of a previous cesarean section, or the abdominal cavity.
None of these locations allow for full fetal development. As the embryo grows, the structure containing it stretches until it ruptures — causing massive internal bleeding that can lead to shock and death within hours if not treated in time.
Location of ectopic pregnancy
2. Risk factors: who has a higher probability
Although ectopic pregnancy can occur in any woman of reproductive age without identifiable risk factors, these history factors multiply the probability:
| Risk factor | Relative risk | Mechanism |
|---|---|---|
| Previous ectopic pregnancy | ×8–10 | Permanent tubal damage from the previous episode |
| Previous tubal surgery (including tubal ligation) | ×6–10 | Anatomical alteration of the tubal lumen |
| Pelvic inflammatory disease (PID) | ×4–8 | Adhesions and ciliary damage from infection (Chlamydia, Neisseria) |
| Assisted reproduction techniques (IVF) | ×2–5 | Embryo transfer into damaged tubes + hyperestrogenism |
| Endometriosis | ×2–3 | Anatomical distortion and tubal ciliary dysfunction |
| IUD in situ (at the time of pregnancy) | ×2–3 | The IUD prevents intrauterine pregnancies — ectopic pregnancies remain possible |
| Active smoking | ×1.5–3 | Alters tubal ciliary mobility and peristalsis |
| Maternal age > 35 years | ×2 | Higher prevalence of cumulative tubal pathology |
| Chlamydia trachomatis infection | ×2–4 | Silent salpingitis with permanent tubal damage |
| No identifiable risk factor | present in ~50% of cases | 50% of ectopic pregnancies occur in women without known risk factors |
3. Symptoms of ectopic pregnancy: the classic triad and beyond
Ectopic pregnancy symptoms can be very similar to those of a normal pregnancy in their early stages, which delays diagnosis. The classic triad is as follows, but it is only fully present in a minority of patients:
Symptoms indicating rupture — EMERGENCY
- • Acute and sudden abdominal pain, of sudden onset
- • Referred pain to the right shoulder (phrenic irritation from hemoperitoneum)
- • Dizziness, syncope, hypotension
- • Pallor, tachycardia, cold sweats
- • Abdominal guarding, board-like abdomen
- • Palpable adnexal mass (in 50% of cases)
- • Pain on cervical mobilization ("Douglas sign")
- • Pain on vaginal touch in the fornices
- • Uterus smaller than expected for amenorrhea
- • Signs of peritoneal irritation upon rupture
4. Diagnosis: the 3-pillar protocol
The diagnosis of ectopic pregnancy is based on three elements that must be evaluated together and, in many cases, serially over 48–72 hours. None of the three, by itself, is sufficient to confirm or exclude the diagnosis.
Ultrasound findings in ectopic pregnancy
| Ultrasound finding | Meaning | Specificity |
|---|---|---|
| Complex extraovarian adnexal mass | Most frequent finding — present in >89% of ectopic pregnancies | High |
| Gestational sac with embryo and ectopic heartbeat | Definitive diagnosis of ectopic pregnancy — in only 10% of cases | Very high (100%) |
| Absence of intrauterine gestational sac with β-hCG > 2,000 | Suggestive of ectopic pregnancy or incomplete abortion — discriminatory zone | Medium-high |
| Intrauterine pseudogestational sac | Intracavitary fluid collection due to decidual reaction — NOT a gestational sac. Key differential diagnosis. | Requires ultrasound expertise |
| Free fluid in the Douglas pouch | Active pelvic bleeding — can be due to rupture or slow tubal bleeding | Medium — can be seen in other conditions |
| Color Doppler: perilesional "fire ring" | High-velocity, low-impedance vascular flow around the ectopic trophoblast | High when present |
| Visible intrauterine yolk sac | Practically excludes ectopic pregnancy — the yolk sac confirms intrauterine pregnancy | Very high (negative for ectopic pregnancy) |
5. Differential diagnosis: what else it could be
Several conditions can mimic ectopic pregnancy. The doctor should always consider them before starting treatment, especially methotrexate, which is contraindicated in viable intrauterine pregnancy:
| Condition | How to differentiate it |
|---|---|
| Incomplete spontaneous abortion | Progressively decreasing β-hCG. Ultrasound echoes of intrauterine remnants. Non-empty uterus. |
| Ruptured corpus luteum cyst | Negative β-hCG (no pregnancy). An adnexal mass with free fluid may be seen — without pregnancy. |
| Very early intrauterine pregnancy | β-hCG below the discriminatory zone — the sac is not yet visible. Serial follow-up is necessary. |
| Heterotopic pregnancy | Simultaneous intrauterine + ectopic. Rare except in IVF (incidence up to 1:100 in assisted reproduction). Seeing an intrauterine sac does not exclude ectopic pregnancy in this context. |
| Pregnancy of unknown location (PUL) | Positive β-hCG, ultrasound without defined intrauterine or extrauterine location. Occurs in 8–14% of cases. Mandatory follow-up until resolution. |
| Acute appendicitis | Negative β-hCG. Right lower quadrant pain. Leukocytosis. No adnexal mass. |
6. Treatment of ectopic pregnancy: the three options
Treatment depends on the patient's hemodynamic status, β-hCG levels, the size of the mass, and the presence or absence of a fetal heartbeat. The three options are:
Option 1: Expectant management (observation)
In highly selected cases, an ectopic pregnancy may resolve spontaneously—approximately 65–70% of ectopic pregnancies with β-hCG < 1,000 mUI/mL that is decreasing resolve without intervention. The criteria for expectant management are strict:
- Complete hemodynamic stability without signs of hemoperitoneum
- β-hCG < 1,000 mUI/mL and spontaneously decreasing
- Adnexal mass < 3 cm without a fetal heartbeat
- No significant abdominal pain
- Ability to provide close follow-up and rapid access to emergency care if deterioration occurs
Option 2: Medical treatment with methotrexate
Methotrexate (MTX) is a folic acid antagonist that inhibits DNA synthesis in rapidly dividing cells—such as those in the trophoblast of an ectopic pregnancy. When administered correctly, it has a 90% success rate in well-selected candidates.
Criteria for methotrexate (all must be met)
- Hemodynamic stability—no signs of rupture or hemoperitoneum
- β-hCG < 5,000 mUI/mL (failure rates increase significantly above this level)
- No fetal heartbeat on ultrasound
- Mass < 3.5–4 cm according to institutional protocol
- Normal renal, hepatic, and hematologic function
- No absolute contraindications (breastfeeding, immunodeficiency, liver disease, kidney disease, blood disorders)
Single-dose protocol (the most commonly used)
| Day | Action | What to expect |
|---|---|---|
| Day 1 | Administer MTX 50 mg/m² IM. Obtain an initial β-hCG measurement. | Mild to moderate abdominal pain may occur on days 3–7 (normal: expulsion of trophoblastic tissue) |
| Day 4 | Repeat β-hCG measurement | The β-hCG may rise slightly before falling—this is normal and does not indicate failure |
| Day 7 | Repeat β-hCG measurement | If it decreases by >15% between day 4 and day 7 → favorable response |
| Following weeks | Weekly β-hCG until it becomes negative | If it does not decrease by >15% on day 7 → second dose of MTX or surgery |
| Until it becomes negative | Avoid sexual intercourse and strenuous physical activity. No NSAIDs. No alcohol. Protect from sunlight. | The ultrasound image may persist for up to 1 year even if the β-hCG is negative |
Option 3: Laparoscopic surgery
This is the treatment of choice when there is rupture, hemodynamic instability, methotrexate failure, or contraindications to medical treatment. Laparoscopy is preferable to laparotomy whenever the patient's condition allows.
7. Ectopic pregnancy and future fertility
One of the most distressing questions is whether it is possible to have a normal pregnancy after an ectopic pregnancy. The general answer is yes—but with important nuances:
- Subsequent intrauterine pregnancy rates: approximately 60–80% of women achieve a successful intrauterine pregnancy after an ectopic pregnancy that is treated correctly, depending on the condition of the contralateral fallopian tube and the underlying cause.
- Recurrence risk: a history of ectopic pregnancy increases the risk of another ectopic pregnancy 8 to 10 times. Therefore, for any new pregnancy, an early transvaginal ultrasound is mandatory to confirm intrauterine localization.
- After methotrexate: it is recommended to wait at least 3 months (some guidelines indicate 6 months) before attempting another pregnancy, given the teratogenic effect of MTX on folate.
- After unilateral salpingectomy: fertility may be preserved with the contralateral fallopian tube. In the case of bilateral damage, assisted reproduction (IVF) is the alternative.
8. What separates a timely diagnosis from an emergency
An ectopic pregnancy diagnosed before rupture can be treated with methotrexate on an outpatient basis, with low risk and preservation of fertility. One diagnosed with rupture requires emergency surgery, blood transfusion, and poses a real risk to life. The difference between the two scenarios is determined primarily by a single tool: early transvaginal ultrasound.
In Colombia, delayed diagnosis of ectopic pregnancy remains frequent for two reasons: atypical clinical presentation and the absence of quality ultrasound at the primary level of care. Every clinic that treats patients of reproductive age should have access to an ultrasound machine with a transvaginal probe and a clear management protocol for pregnancy of uncertain location.
Transvaginal ultrasound saves lives—it is the gold standard for diagnosing ectopic pregnancy
Gynecological and obstetric ultrasound machines with an endocavitary probe, color Doppler, and reference diagnostic quality, available in Colombia with local technical support.
View ultrasound machines for gynecology and obstetrics →
